1-3 of 3
Antonio Castagnoli, MD
Close
Sort by
Journal Articles

Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial

Anne Ségolène Cottereau, MD, Annibale Versari, MD, Annika Loft, MD PhD, Rene-Olivier Casasnovas, MD, Monica Bellei, Romain Ricci, Stephane Bardet, Antonio Castagnoli, MD, Pauline Brice, MD, John Raemaeker, Emmanuel Itti, MD PhD, Catherine Forpied, Tiana Raveloarivahy, Theodore Girinsky, Thierry Van der Borght, Massimo Federico, MD PhD, Martin Hutchings, Umberto Ricardi, Michel Meignan, MD PhD, Marc Andre, MD
Journal: Blood
Blood (2016) 128 (22): 184.
https://doi.org/10.1182/blood.V128.22.184.184
Published: 2016
Journal Articles

Comparison between 2-Deoxy-2-[18f]Fluoro-D-Glucose Positron Emission (FDG-PET) and Computed Tomography (CT) for Staging of Patients with Hodgkin’s Lymphoma (HL).

Luigi Rigacci, MD, Francesco Merli, MD, Antonio Castagnoli, MD, Annibale Versari, MD, Luca Nassi, MD, Ida Capodanno, MD, Teodoro Chisesi, MD, Andrea Gallamini, MD, Alberto Biggi, MD, Umberto Vitolo, MD, Silvia Tavera, MD, Rosaria Sancetta, MD, Patrizia Pregno, MD, Francesca Salvi, MD, Ettore Pelosi, MD, Alessandro Levis, MD, Alberto Bosi, MD.
Journal: Blood
Blood (2005) 106 (11): 975.
https://doi.org/10.1182/blood.V106.11.975.975
Published: 2005
Journal Articles

Predictive Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Performed after Two Cycles of Standard Chemotherapy (CT) on Treatment Outcome in Hodgkin Disease.

Andrea Gallamini, MD, Luigi Rigacci, MD, Francesco Merli, MD, Pasquale Errico, MD, Alessandro Levis, MD, Alberto Biggi, MD, Antonio Castagnoli, MD, Silvia Tavera, MD, Luca Nassi, MD
Journal: Blood
Blood (2004) 104 (11): 310.
https://doi.org/10.1182/blood.V104.11.310.310
Published: 2004